Skip to main content
SpringerLink
Log in

Treatment and Prophylaxis of Anthrax by New Neurosecretory Cytokines

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

In 1881, Louis Pasteur described the Bacillus anthracis vaccine, which plays an important role for the treatment and prophylaxis of anthrax. Currently, treatment for anthrax infection involves the use of several different antibiotics, used in combination with vaccines, which possess potential virulence in white mice and guinea pigs. We discovered several new immunomodulators cytokines (polypeptides) produced by the neurosecretory cells of hypothalamus, some of which can be used as drugs for the treatment and prophylaxis of the anthrax. The proline-rich polypeptides, which consist from 10 to 15 amino acids and four proline residues, are of the special interest; one of them (PRP-1), which consist of 15 amino acids and has the following primary structure ALa-GLy-ALa-Pro-GLu-Pro-Ala-GLu-Pro-Ala-GLn-Pro-GLy-Val-Tyr (AGAPEPAEPAQPGVY) possesses antibacterial activity, and a new proline-rich peptide described by Galoyan and called G x -NH2. Both were tested for treatment against the anthrax bacillus or anthrax strain N55 vaccine in guinea pigs and mice in vivo, and in vitro preparations. The results of experiments show that these hypothalamic neurosecretory cytokines have a strong prophylaxis and therapeutic properties towards animals infected by episodic strain of anthrax and anthrax vaccine N55. The conventional concepts concerning the function of hypothalamic neurosecretion and hypothalamic mechanisms of adaptation have to be reconsidered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Brossier F, Weber-Levy M, Mock M, Sirard JC (2000) Role of toxin functional domains in anthrax pathogenesis. Infect Immun 68:1781–1786

    Article  PubMed  CAS  Google Scholar 

  2. Mourez M, Lacy DB, Conningham K et al. (2002) A year of major advances in anthrax toxin research. Trends Microbiol 10:287–293

    Article  PubMed  CAS  Google Scholar 

  3. Bradley KA, Young JAT (2003) Anthrax toxin receptor proteins. Biochem Pharmacol 65:309–314

    Article  PubMed  CAS  Google Scholar 

  4. Leppla SH (1982) Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentration in eukaryotic cells. PNAS USA 79:3162–3166

    Article  PubMed  CAS  Google Scholar 

  5. O’Brien J, Friedlander AM, Dreier T, Ezzell J, Leppla S (1985) Effects of anthrax toxin components on human neutrophils. Infect Immun 47:306–410

    Google Scholar 

  6. Ross JM (1957) The pathogenesis of anthrax following the administration of spores by the respiratory route. J Pathol Bacteriol 73:485–494

    Article  Google Scholar 

  7. Hanna P (1998) Anthrax pathogenesis and host response. Curr Top Microbiol Immunol 225:13–35

    PubMed  CAS  Google Scholar 

  8. Lalitha MK, Thomas MK (1997) Penicillin resistance in Bacillus anthracis. Lancet 349:1522

    Article  PubMed  CAS  Google Scholar 

  9. Chen Y, Succi J, Tenovez FC, Kochler TM (2003) Beta-Lactamase Genes of the Penicillin-Cusceptible Bacillus anthracis Sterne Strain. J Bacteriol 185:823–830

    Article  PubMed  CAS  Google Scholar 

  10. Swartz MN (2001) Recognition and management of anthrax – an update. N Engl J Med 345:1621–1626

    Article  PubMed  CAS  Google Scholar 

  11. Ressel G (2001) CDC updates interim gyidelines for anthrax exposure management and antimicrobal therapy. Am Fam Physicion 64:1901–1902

    CAS  Google Scholar 

  12. Borg MA, Tieck WC (2001) Responding to anthrax. J Dent Technol 18:12–14, 28

    Google Scholar 

  13. Brook J (2002) The prophylaxis and treatment of anthrax. Inf J Antimicrob Agents 20(5):320–325

    Google Scholar 

  14. Bryskier A (2002) Bacillus anthracis and antibacterial agents. Clin Microbiol Infect 8:467–478

    Article  PubMed  CAS  Google Scholar 

  15. Odendaal MW, Peterson PM, de Voc V, Botha AD (1991) The antibiotic sensitivity patterns of Bacillus anthracis isolated from the Kruger National park. Onderstepoort J Vct Res 58:17–19

    Google Scholar 

  16. Doganaya M, Aydin N 1991 Antimicrobial susceptibility of Bacillus anthracis. Scand J Infect Dis 23:333–335

    Article  Google Scholar 

  17. Ingles TV, Handerson DA, Bartlett JG et al. (1999) Anthrax as a biological weapon. JAMA 128(18):1735–1745

    Article  Google Scholar 

  18. Aprikyan VS, Galoyan AA (1999) Immunecorrecting properties of a new hypothalamic polypeptide upon macrophage-associated bacterial dysfunction. Med Sci Armenia 31(4):29–36

    Google Scholar 

  19. Davtyan TK, Manukyan NA, Mkrtchyan R, Galoyan AA (2005) Hypothalamic Proline-Rich Polypeptide (PRP) is a regulator of human Neutrophils and Monocytes oxidative burst. Neurochem Res 3:297–309

    Article  Google Scholar 

  20. Galoyan AA, Aprikyan VS (2002) A new hypothalamic peptide is a regulator of myelopoiesis. Neurochem Res 27:305–312

    Article  PubMed  CAS  Google Scholar 

  21. Aprikyan VS, Galoyan AA (2001) New hypothalamic peptides in regulation of thymocytes differentiation. Proceeding of the International conference “Biochemical and Molecular-Biological aspects of Brain Immune System. Encyclopedia Armenica publishing House, Yerevan, pp 183–189

  22. Aprikyan VS, Galoyan AA (2000) Hypothalamic polypeptide protects mice from lethal challenge with gram-negative bacteria. Neurokhimya RAS NAS RA 17:60–63

    CAS  Google Scholar 

  23. Galoyan AA (2004) Brain neurosecretory cytokines; immune response and neuronal survival. Kluwer Academic/Plenum Publishers, New York, p 188

  24. Galoyan AA (2005) The chemistry and molecular biology of new brain cytokines. Proceedings of the International Scientific Conference dedicated to the 75th anniversary of YSMU, Yerevan, pp 135–136

  25. Pellizzari R, Guidi-Rontani C, Vitale G, Mick U, Montecucco C (1999) Anthrax lethal factor cleves MkK3 in macrophages and inhibits the LPS/IFN gamma-induced release of NO and TNFalpha. FEBS Lett 462:199–204

    Article  PubMed  CAS  Google Scholar 

  26. Park JM, Greten FR, Li ZW, Karin M (2002) Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297(5589):2048–2051

    Article  PubMed  CAS  Google Scholar 

  27. Guidi-Ronfani Ch, Levy M, Ohayon H, Mock M (2002) Fate of germinated Bacillus anthracis spores in primary macrophages. Mol Microbiol 42(4):931

    Article  Google Scholar 

  28. Rontani Chantal-Guidi, Leve Martine, Ohayon Helene, Mock Michele (2001) Fate of germinated Bacillus anthracis spores in primary murine macrophages. Mol Microbiol 42(4):931

    Google Scholar 

  29. Pickering AK, Merkel TJ (2004) Macrophages release tumor necrosis factor alpha and Interleukin-12 in response to intracellular Bacillus anthracis spores. Infect Immun 72:3069–3072

    Article  PubMed  CAS  Google Scholar 

  30. Dixon TC, Fahd AA, Koehler TM, Swanson JA, Hanna PC (2000) Early events in anthrax pathogenesis, intracellular survival of B. anthracis and escape RAW 264.7 macrophages. Cell Microbiol 2:453–463

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurohormone Biochemistry, Buniatian Institute of Biochemistry NAS RA, 5/1 Sevag Str., Yerevan, 375014, Armenia

    A. A. Galoyan & K. V. Badalyan

  2. Department of Epidemiology, Armenian State Agriculture University, 75, Teryan Str., Yerevan, 375025, Armenia

    S. L. Grigoryan

Authors
  1. A. A. Galoyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. L. Grigoryan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. V. Badalyan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. A. Galoyan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galoyan, A.A., Grigoryan, S.L. & Badalyan, K.V. Treatment and Prophylaxis of Anthrax by New Neurosecretory Cytokines. Neurochem Res 31, 795–803 (2006). https://doi.org/10.1007/s11064-006-9082-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-006-9082-2

Keywords

Search

Navigation